1. Home
  2. CLLS vs WRN Comparison

CLLS vs WRN Comparison

Compare CLLS & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • WRN
  • Stock Information
  • Founded
  • CLLS 1999
  • WRN 2006
  • Country
  • CLLS France
  • WRN Canada
  • Employees
  • CLLS N/A
  • WRN N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • WRN Metal Mining
  • Sector
  • CLLS Health Care
  • WRN Basic Materials
  • Exchange
  • CLLS Nasdaq
  • WRN Nasdaq
  • Market Cap
  • CLLS 240.2M
  • WRN 237.4M
  • IPO Year
  • CLLS 2007
  • WRN N/A
  • Fundamental
  • Price
  • CLLS $1.57
  • WRN $1.04
  • Analyst Decision
  • CLLS Buy
  • WRN Strong Buy
  • Analyst Count
  • CLLS 3
  • WRN 1
  • Target Price
  • CLLS $7.00
  • WRN $4.25
  • AVG Volume (30 Days)
  • CLLS 59.8K
  • WRN 196.5K
  • Earning Date
  • CLLS 11-04-2024
  • WRN 11-07-2024
  • Dividend Yield
  • CLLS N/A
  • WRN N/A
  • EPS Growth
  • CLLS N/A
  • WRN N/A
  • EPS
  • CLLS N/A
  • WRN N/A
  • Revenue
  • CLLS $36,042,000.00
  • WRN N/A
  • Revenue This Year
  • CLLS $271.02
  • WRN N/A
  • Revenue Next Year
  • CLLS $33.48
  • WRN N/A
  • P/E Ratio
  • CLLS N/A
  • WRN N/A
  • Revenue Growth
  • CLLS 46.96
  • WRN N/A
  • 52 Week Low
  • CLLS $1.53
  • WRN $0.95
  • 52 Week High
  • CLLS $3.55
  • WRN $1.66
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 27.91
  • WRN 40.52
  • Support Level
  • CLLS $1.85
  • WRN $0.99
  • Resistance Level
  • CLLS $2.09
  • WRN $1.14
  • Average True Range (ATR)
  • CLLS 0.09
  • WRN 0.04
  • MACD
  • CLLS -0.04
  • WRN -0.01
  • Stochastic Oscillator
  • CLLS 0.00
  • WRN 25.00

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).

Share on Social Networks: